2502 related articles for article (PubMed ID: 23151605)
1. Immunogenic cell death and DAMPs in cancer therapy.
Krysko DV; Garg AD; Kaczmarek A; Krysko O; Agostinis P; Vandenabeele P
Nat Rev Cancer; 2012 Dec; 12(12):860-75. PubMed ID: 23151605
[TBL] [Abstract][Full Text] [Related]
2. Many faces of DAMPs in cancer therapy.
Krysko O; Løve Aaes T; Bachert C; Vandenabeele P; Krysko DV
Cell Death Dis; 2013 May; 4(5):e631. PubMed ID: 23681226
[TBL] [Abstract][Full Text] [Related]
3. An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer.
Wang L; Guan R; Xie L; Liao X; Xiong K; Rees TW; Chen Y; Ji L; Chao H
Angew Chem Int Ed Engl; 2021 Feb; 60(9):4657-4665. PubMed ID: 33217194
[TBL] [Abstract][Full Text] [Related]
4. The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: From sensor to the plasma membrane and beyond.
van Vliet AR; Martin S; Garg AD; Agostinis P
Semin Cancer Biol; 2015 Aug; 33():74-85. PubMed ID: 25882379
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies.
Wang Q; Ju X; Wang J; Fan Y; Ren M; Zhang H
Cancer Lett; 2018 Dec; 438():17-23. PubMed ID: 30217563
[TBL] [Abstract][Full Text] [Related]
6. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death.
Garg AD; Krysko DV; Verfaillie T; Kaczmarek A; Ferreira GB; Marysael T; Rubio N; Firczuk M; Mathieu C; Roebroek AJ; Annaert W; Golab J; de Witte P; Vandenabeele P; Agostinis P
EMBO J; 2012 Mar; 31(5):1062-79. PubMed ID: 22252128
[TBL] [Abstract][Full Text] [Related]
7. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.
Inoue H; Tani K
Cell Death Differ; 2014 Jan; 21(1):39-49. PubMed ID: 23832118
[TBL] [Abstract][Full Text] [Related]
8. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.
Solari JIG; Filippi-Chiela E; Pilar ES; Nunes V; Gonzalez EA; Figueiró F; Andrade CF; Klamt F
BMC Cancer; 2020 May; 20(1):474. PubMed ID: 32456685
[TBL] [Abstract][Full Text] [Related]
9. The copper (II) complex of salicylate phenanthroline induces immunogenic cell death of colorectal cancer cells through inducing endoplasmic reticulum stress.
Chen M; Wang D; Fan L; Niu D; Xu J; Liu Y; Liu Y
Int Immunopharmacol; 2024 May; 132():111980. PubMed ID: 38555819
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic Apoptotic Cell Death and Anticancer Immunity.
Vandenabeele P; Vandecasteele K; Bachert C; Krysko O; Krysko DV
Adv Exp Med Biol; 2016; 930():133-49. PubMed ID: 27558820
[TBL] [Abstract][Full Text] [Related]
11. Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer.
Fucikova J; Kasikova L; Truxova I; Laco J; Skapa P; Ryska A; Spisek R
Immunol Lett; 2018 Jan; 193():25-34. PubMed ID: 29175313
[TBL] [Abstract][Full Text] [Related]
12. Combining cisplatin with Pinellia pedatisecta Schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer.
Wang C; Zhang M; Peng J; Zhang M; Lu C; Qi X; Luo Q; Wang Y; Li G
Phytomedicine; 2024 Jun; 128():155504. PubMed ID: 38452404
[TBL] [Abstract][Full Text] [Related]
13. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.
He Z; Jing X; Dai X; Bao L; Yang X; Xiong Y; Li M
Front Biosci (Landmark Ed); 2024 Apr; 29(4):158. PubMed ID: 38682206
[TBL] [Abstract][Full Text] [Related]
14. Biphasic Increases of Cell Surface Calreticulin Following Treatment with Mitoxantrone.
Azuma Y; Suzuki K; Higai K; Matsumoto K; Tada S
Biol Pharm Bull; 2020 Oct; 43(10):1595-1599. PubMed ID: 32727970
[TBL] [Abstract][Full Text] [Related]
15. High hydrostatic pressure induces immunogenic cell death in human tumor cells.
Fucikova J; Moserova I; Truxova I; Hermanova I; Vancurova I; Partlova S; Fialova A; Sojka L; Cartron PF; Houska M; Rob L; Bartunkova J; Spisek R
Int J Cancer; 2014 Sep; 135(5):1165-77. PubMed ID: 24500981
[TBL] [Abstract][Full Text] [Related]
16. Targeting immunogenic cell death in cancer.
Ahmed A; Tait SWG
Mol Oncol; 2020 Dec; 14(12):2994-3006. PubMed ID: 33179413
[TBL] [Abstract][Full Text] [Related]
17. Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells.
D'Eliseo D; Manzi L; Velotti F
Cell Stress Chaperones; 2013 Nov; 18(6):801-8. PubMed ID: 23580156
[TBL] [Abstract][Full Text] [Related]
18. Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner.
Yang Y; Li XJ; Chen Z; Zhu XX; Wang J; Zhang LB; Qiang L; Ma YJ; Li ZY; Guo QL; You QD
PLoS One; 2012; 7(12):e50811. PubMed ID: 23251389
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives.
Aria H; Rezaei M
Biomed Pharmacother; 2023 May; 161():114503. PubMed ID: 36921539
[TBL] [Abstract][Full Text] [Related]
20. ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin.
Obeid M
J Immunol; 2008 Aug; 181(4):2533-43. PubMed ID: 18684944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]